PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0409974|lupus erythematosus |
| Sentences | 30 |
| PubMedID- 22910888 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [132]. |
| PubMedID- 22194660 | In addition, very recently, mcmahon and colleagues have demonstrated that leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus and that there is no significant association between adiponectin and atherosclerotic plaques in sle [24]. |
| PubMedID- 22709931 | The detection of autoantibodies to atp-binding cassette transporter a1 and its role in the pathogenesis of atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 23526148 | Th17/treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 24261762 | Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 20132070 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 23620348 | Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21670088 | High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. |
| PubMedID- 25638414 | Striking phenomena of atherosclerosis associated with systemic lupus erythematosus (sle) is its high incidence in young patients. |
| PubMedID- 26251402 | Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21280004 | Objective: an increased risk of premature atherosclerosis has been associated with systemic lupus erythematosus (sle), and type i interferon (ifn) has been shown to play a pathogenic role in human sle. |
| PubMedID- 26455562 | Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. |
| PubMedID- 23060481 | We hypothesized that increased inflammation is associated with increased ffas, resulting in insulin resistance and atherosclerosis in patients with systemic lupus erythematosus (sle). |
| PubMedID- 23084817 | Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials. |
| PubMedID- 20682673 | Nuclear magnetic resonance lipoprotein subclasses and the apoe genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 21110795 | Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus: comments on the article by mok et al. |
| PubMedID- 24711757 | Hcq might have improved vascular function in our study population, since it has been shown to exert a mild protective effect against atherosclerosis in patients with systemic lupus erythematosus (45). |
| PubMedID- 26424129 | Low bone mass and carotid atherosclerosis in lupus erythematosus patients from granada, a city in the south of spain. |
| PubMedID- 23082493 | Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 26183767 | Cd4+cxcr3+ t cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus. |
| PubMedID- 24790989 | atherosclerosis is accelerated in patients with systemic lupus erythematosus (sle) and it leads to excessive cardiovascular complications in these patients. |
| PubMedID- 24699314 | Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. |
| PubMedID- 20813797 | To assess aortic stiffness by transesophageal echocardiography (tee) and to determine its clinical predictors and relation to age, blood pressure, renal function, and atherosclerosis, 50 patients with systemic lupus erythematosus (sle), 94% women, with a mean age of 38 +/- 12 years, and 22 age and gender-matched healthy controls underwent clinical and laboratory evaluations and multiplane tee to assess stiffness, intima-media thickness (imt), and plaques of the proximal, mid, and distal descending thoracic aorta. |
| PubMedID- 19687018 | Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study. |
| PubMedID- 24478772 | However, high levels of stweak were associated with atherosclerosis in patients with systemic lupus erythematosus (sle), but not in control subjects (87). |
| PubMedID- 24376005 | Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. |
| PubMedID- 22196362 | Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. |
| PubMedID- 24021339 | Objectives: although a series of trials support systemic lupus erythematosus (sle) is associated with increased atherosclerosis and cardiovascular events, the link between microvascular structural change and the disease activity of sle is not defined. |
| PubMedID- 20044088 | Background: systemic lupus erythematosus (sle) is associated with premature atherosclerosis but the mechanisms underlying this association are not understood. |
| PubMedID- 25159099 | We sought to investigate the relationship between bmd and vf and carotid atherosclerosis in women with systemic lupus erythematosus (sle). |
Page: 1